medigraphic.com

2000, Number 6

<< Back Next >>

Arch Cardiol Mex 2000; 70 (6)

Metabolic therapy with glucose-potassium-insulin. A historical overview

Micheli A

Language: Spanish
References: 62
Page: 609-615
PDF size: 132.17 Kb.


Text Extraction

No abstract


REFERENCES

  1. Núñez R, Calva E, Briones E, López Soriano F: Cambios en los nucleótidos de nicotinamida adenina tisulares durante el infarto experimental del miocardio. Memorias del VI Congreso Mexicano de Cardiología. México, 1969: 160-161.

  2. Braasch W, Gudbjarnason S, Puri PS, Ravens KG, Bing RJ: Early changes in energy metabolism in the myocardium following acute coronary artery occlusion in anesthetized dogs. Circ Res 1968; 23: 429-438.

  3. 2a. De Micheli A: Las bases racionales del tratamiento polarizante en el infarto del miocardio. Arch Inst Cardiol Mex 1969; 39: 713-731.

  4. Calva E, Trillo A, Núñez R, Aoki K, Ariza D: Relaciones entre los cambios bioquímicos y ultraestructurales del corazón con infarto experimental. Arch Inst Cardiol Mex 1969; 39: 696-712.

  5. Gudbjarnason S, Braasch W, Cowan C, Bing RJ: Metabolism of infarcted heart muscle during tissue repair. Am J Cardiol 1968; 22: 360-369.

  6. Manning JP, Pensinger RR, Fehn PA: Cardiac alkaline and acid phosphatase activity and potassium concentration in dog with acute myocardial infarction. Cardiovasc Res 1968; 2: 308-313.

  7. Ravens KG, Gudbjarnason S: Changes in the activities of lysosomal enzymes in infarcted canine heart muscle. Circ Res 1969; 24: 851-856.

  8. Yamamura Y: Energy metabolism in myocardium. Jpn Circ J 1968; 32: 1801-1804.

  9. Gudbjarnason S, De Schryver C, Chiba C, Yamanaka J, Bing RJ: Protein and nucleic acid synthesis during the reparative process following myocardial infarction. Circ Res 1964; 15: 320-326.

  10. Flower R: Glucocorticoids, phospholipase A2 and inflammation. Trends Pharmacol Sci 1981; 2: 186-189.

  11. Larcan A, Huriet C: L’électrocardiogramme dysmétabolique. París. Ed. Masson & Cie, 1959.

  12. Olson RE: Metabolic interventions in the treatment of infarcting myocardium. Circulation 1969; 40(Suppl 4): 195-201.

  13. De Micheli A: Enfoque racional de ciertos aspectos diagnósticos y terapéuticos del infarto del miocardio. Arch Inst Cardiol Mex 1971; 41: 340-356.

  14. Janusckevicius ZI, Blujas II, Vitkus AS: Lecenie infarkta miokarda poljarizujutscei i fibrinolizinpoljarizutscei smesjani. (Tratamiento del infarto del miocardio con la solución polarizante y la mezcla fibrinolisin-polarizante). Kardiologiia 1966; 6(4): 48-53

  15. Smith AE, Luten D: Study of glucose therapy in heart failure in advanced cardiac disease. Am Heart J 1934; 9: 437-446.

  16. Kisthinios N: Le traitement des cardiopathies par l’association sucre-insuline. París. JB Baillière et Fils, 1933.

  17. Olascoaga JQ: Principales acciones fisiológicas de la combinación azúcar-insulina en terapéutica cardiaca. (Tesis recepcional). México. UNAM, 1933.

  18. Iseri LT, Alexander LC, Mc Caughey RS, Bayle AJ, Myers GB: Water and electrolyte content of cardiac and skeletal muscle in heart failure and myocardial infarction. Am Heart J 1952; 43: 215-227.

  19. Hazard J: Le potassium en biologie et en thérapeutique. París. Ed. Exp Scient Franç, 1954.

  20. McAllen PM: Myocardial changes occurring in potassium deficiency. Br Heart J 1955; 17: 5-14.

  21. Selye H: The chemical prevention of cardiac necrosis. Nueva York. The Ronald Press Co, 1958.

  22. Michon P, Larcan A, Gaucher P: Potassium et énergétique myocardique. Sem Hôp Paris 1959; 35: 3289.

  23. Sodi Pallares D, de Micheli A: Un tentativo di reintegrazione ionica cellulare in alcune malattie cardiovascolari. Atti Acc Med Lombarda 1962; 17(4): 509-519.

  24. Haneda T, Ganz W, Lee T, Katz J: Reduction of myocardial oxygen demand by glucose-insulin-potassium (GIK). Circulation 1974; 50 (Suppl. III): 102.

  25. Opie LH: Metabolism of free fatty acids, glucose, and catecholamines in acute myocardial infarction. Am J Cardiol 1975; 36: 938-953.

  26. Opie LH, Bricknel OL: Role of glycolitic flux in effect of glucose in decreasing fatty acid-induced decrease of lactate dehydrogenase from isolated coronary ligated rat heart. Cardiovasc Res 1979; 13: 693-702.

  27. De Micheli A, Medrano GA, Sodi Pallares D: Efectos de algunas soluciones electrolíticas sobre la evolución electrocardiográfica del infarto experimental agudo del miocardio. Arch Inst Cardiol Mex 1963; 33: 567-580.

  28. Sodi Pallares D, Bisteni A, Medrano GA, Testelli MR, de Micheli A: The polarizing treatment of acute myocardial infarction: Possibility of its use in other cardiovascular conditions. Dis Chest 1963; 43: 424-432.

  29. Calva E, Mújica A, Bisteni A, Sodi Pallares D: Oxidative phosphorylation in cardiac infarct. Effect of glucose-KCl-insulin solution. Am J Physiol 1965; 209: 375-380.

  30. Calva E, Mújica A, Núñez R, Aoki K, Bisteni A, Sodi Pallares D: Mitochondrial biochemical changes and glucose-KCl-insulin solution in cardiac infarct. Am J Physiol 1966; 211: 71-76.

  31. Sybers HD, Maroko PR, Ashraf M, Libby P, Braunwald E: The effect of glucose-insulin-potassium on cardiac ultrastructures following acute experimental coronary occlusion. Am J Pathol 1973; 70: 401-420.

  32. Prasad K, Callaghan JC: Effects of glucose metabolism on the transmembrane action potential and contraction of human papillary muscle during surgical anoxia. Ann Thorac Surg 1969; 7: 571-580.

  33. Prasad K, Callaghan JC: Electrophysiologic basis of use of a polarizing solution in the treatment of myocardial infarction. Clin Pharmacol Ther 1971; 12: 666-675.

  34. De Micheli A, Medrano GA, Villarreal A, Sodi Pallares D: Superiority of the glucose-potassium-insulin solution over the glucose, glucose-insulin and glucose-potassium solutions in acute experimental digitalis intoxication. Acta Cardiol 1971; 26(4): 400-417.

  35. De Micheli A, Medrano GA, Villarreal A, Sodi Pallares D: Observaciones sobre la intoxicación quinidínica aguda experimental. Arch Inst Cardiol Mex 1972; 42(4): 580-588.

  36. De micheli A, Medrano GA, Villarreal A, Sodi Pallares D: Efecto protector de la solución glucosa-insulina-potasio en el daño miocárdico producido por emetina. Arch Inst Cardiol Mex 1975; 45(4): 469-486.

  37. Murphy ML, Bulloch RT, Pearce MB: The correlation of metabolic and ultrastructural changes in emetine myocardial toxicity. Am Heart J 1974; 87: 105-108.

  38. De Micheli A, Medrano GA, Testelli M, Sodi Pallares D: L’action de certaines substances chimiques sur l’électrogramme, l’électrocardiogramme et la courbe de tension artérielle chez le chien. Mal Cardiovasc 1963; 4: 607-649.

  39. Hess ML, Okabe E, Poland J, Werner M, Stewart JR, Greenfield LJ: Glucose, insulin, potassium protection during the course of hypothermic global ischemia and reperfusion; a new proposed mechanism by the scavenging of free radicals. J Cardiovasc Pharmacol 1983; 5: 35-43.

  40. Doenst T, Richwine RT, Bray MS, Gary W, Goodwin GW, Frazier OH, et al: Insulin improves functional and metabolic recovery of reperfused working rat heart. Ann Thorac Surg 1999; 67(6): 1682-1688.

  41. Lal HB, Caroli RK: Observations on 400 cases of acute myocardial infarction treated with insulin-potassium and dextrose infusions. Ind J Med Res 1968; 56 (Suppl): 1120.

  42. Sodi Pallares D, de Micheli A, Medrano G, Fishleder B, Bisteni A, Friedland C, Testelli M: Effets sur l’électrocardiogramme de la solution glucose-insuline-potassium au cours de l’insuffisance coronarienne aiguë et chronique. Mal Cardiovasc 1962; 3(1): 41-79.

  43. Sodi Pallares D, Testelli MR, Fishleder BL, Bisteni A, Medrano GA, Friedland C, de Micheli A: Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol 1962; 9(2): 166-181.

  44. Mittra B: Use of potassium, glucose and insulin in the treatment of myocardial infarction. Prog Cardiovasc Dis 1968; 10: 529-544.

  45. Rogers WJ, Russell RO Jr, McDaniel HG, Rackley CE: Effects of glucose-insulin-potassium infusion on myocardial metabolism in man. Am J Cardiol 1977; 40: 421-428.

  46. Rogers WJ, Segall PH, McDaniel HG, Mantle JA, Russell RO Jr, Rackley CE: Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction. Effects on myocardial hemodynamics, substrates and rhythm. Am J Cardiol 1979; 43: 801-809.

  47. Mantle JA, Rogers WJ, Smith LR, McDaniel HG, Papapietro SE, Russell RO Jr, Rackley CE: Clinical effects of glucose-insulin-potassium on left ventricular function in acute myocardial infarction. Results from a randomized clinical trial. Am Heart J 1981; 102: 313-324.

  48. Taegtmeyer H, Goodwin GW, Doenst T, Frazier OH: Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol 1997; 80: 3A-10A.

  49. 47a. Fath-Ordoubadi F, Beatt KJ: Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 1997; 96: 1152-1156.

  50. Díaz R, Paolasso EA, Piegas LS, Tajer CD, Gil Moreno M, Corvalán R, et al: Metabolic modulation of acute myocardial infarction. The ECLA glucose-insulin-potassium pilot trial. Circulation 1998; 98: 2227-2234.

  51. Apstein CS: Glucose-insulin-potassium for acute myocardial infarction. Remarkable results from a new prospective, randomized trial. Circulation 1998; 98: 2223-2226.

  52. Marano L, Bestetti A, Lomuscio A, Tagliabue L, Castini D, Torricone D, et al: Effects of infusion of glucose-insulin-potassium on myocardial function after a recent myocardial infarction. Acta Cardiol 2000; 55(1): 9-15.

  53. Moffitt EA, Rosevear JW, Molnar GD, McGoon DC: Effect of glucose, insulin, potassium solution on ketosis following cardiac surgery. Anesth Analg 1971; 50: 291-297.

  54. Moffitt EA, Rosevear JW, McGoon DC: Myocardial metabolism in children having open-heart surgery. JAMA 1970; 211: 1518-1524.

  55. Moffitt EA, Rosevear JW, McGoon DC: Myocardial metabolism during and after mitral valve replacement. Ann Thorac Surg 1970; 10: 169-179.

  56. Girard C, Quentin P, bouvier H, Blanc P, Bastien O, Lehot JJ, et al: Glucose and insulin supply before cardiopulmonary bypass in cardiac surgery: a double-blind study. Ann Thorac Surg 1992; 54: 259-263.

  57. Besogul Y, Tunerir S, Asian R, Isiksoy S, Colak O, Kural T: Clinical, biochemical and histochemical assessment of pretreatment with glucose-insulin-potassium for patients undergoing mitral valve replacement in the third and fourth functional groups of the New York Heart Association. Cardiovasc Surg 1999; 7(6): 645-650.

  58. Dainese L, Polvani GL, Fumero A, Spirito R, Alamanni F, Agrifoglio M, et al: Glucosa-insulina-potassio (GIK) nella riduzione dell’ischemia miocardica acuta dopo intervento di bypass aorto-coronario. G Ital Cardiol 1999; 29(5): 575-579.

  59. Harold L, Lazar MD: Enhanced preservation of acutely ischemic myocardium using glucose-insulin-potassium solution. J Cardiovasc Surg 1994; 9(Suppl): 474-478.

  60. Apstein CS, Opie LH: Glucose-insulin-potassium (GIK) for acute myocardial infarction: a negative study with a positive value. Cardiovasc Drugs Ther 1999; 13(3): 185-189.

  61. Ceremuzynski L, budoj A, Czapiel A, Burzykowski T, Achremczyk P, Smielakkorombel W, et al: Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: Results of a randomized multicenter Pol-GIK trial. Cardiovasc Drugs Ther 1999; 13(3): 191-200.

  62. Michaels AD, Gibson CM, Barron HV: Microvascular dysfunction in acute myocardial infarction: Focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon. Am J Cardiol 2000; 85: 50B-60B.




2020     |     www.medigraphic.com